Non-Involuting Congenital Hepatic Hemangioma: Lessons from a Case Series
Authors:
- Karla Estefanía-FernándezKEKarla Estefanía-Fernández
- Paloma TrianaPTPaloma Triana
- Carla Ramírez-AmorósCRCarla Ramírez-Amorós
- Mireia Gaspar-PérezMGMireia Gaspar-Pérez
- Antonio Jesús Muñoz-SerranoAMAntonio Jesús Muñoz-Serrano
- María VelayosMVMaría Velayos
- María San BasilioMBMaría San Basilio
- Nelson M. BuitragoNBNelson M. Buitrago
- Manuel ParrónMPManuel Parrón
- Ane AndrésAAAne Andrés
- Francisco Hernández-OliverosFHFrancisco Hernández-Oliveros
- Juan Carlos López GutiérrezJGJuan Carlos López Gutiérrez
Open Access
Abstract
Background: Congenital hepatic hemangiomas (CHHs) are typically considered rapidly involuting tumors, similar to their cutaneous counterparts (RICHs). However, non-involuting tumors remain poorly characterized. This study examines the evolutionary patterns and management strategies for non-involuting congenital hepatic hemangiomas (NICHHs). Methods: We conducted a retrospective review of clinical, imaging, histological, and genetic data of children diagnosed with NICHH—defined as showing no signs of involution for at least 18 months—between 1991 and 2022. Results: Seven patients (five females, two males) were identified. The median age at diagnosis was 42 days (range: 0–1440). Five patients had asymptomatic lesions, predominantly located in the right hepatic lobe. Histologic confirmation was available in three cases, and a GNAQ gene mutation was identified in one. The median follow-up period was 75 months (range: 35–191). Three patients with giant NICHH were treated with sirolimus, resulting in partial response in two cases and lesion stabilization in one. The four untreated patients showed diverse evolutionary patterns, including delayed involution and tardive growth. Conclusions: NICHH lesions demonstrate distinct long-term evolution. Accurate diagnosis and regular monitoring are essential to avoid unnecessary interventions. Sirolimus may offer a promising non-surgical treatment for select patients, particularly those with giant lesions.Keywords
All Related Versions
This publication has 31 references indexed in Scilit:
- Mortality predictive factors in congenital hepatic hemangioma: a case–control studyEuropean Journal of Pediatrics, 2023
- Spontaneous evolution patterns of focal congenital hepatic hemangiomas: a case series of 25 patientsPediatric Radiology, 2022
- Resection of the largest reported hepatic small vessel neoplasmHuman Pathology, 2018
- Epithelioid hemangioendotheliomas of the liver and lung in children and adolescentsPediatric Blood & Cancer, 2017
- Hepatic small vessel neoplasm, a rare infiltrative vascular neoplasm of uncertain malignant potentialHuman Pathology, 2016
- Prevalence and clinical outcome of hepatic haemangioma with specific reference to the risk of rupture: A large retrospective cross-sectional studyDigestive and Liver Disease, 2016
- Rapidly involuting congenital haemangioma (RICH) of the liverPediatric Radiology, 2012
- The risk of spontaneous rupture of liver hemangiomas: a critical review of the literatureJournal of Hepato-Biliary-Pancreatic Sciences, 2011
- Treatment of childhood kaposiform hemangioendothelioma with sirolimusPediatric Blood & Cancer, 2010
- Rapidly Involuting Congenital Hemangioma: Clinical and Histopathologic FeaturesPediatric and Developmental Pathology, 2003